WallStSmart

Agilent Technologies Inc (A)vsAdvanced Biomed Inc. Common Stock (ADVB)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

A leads profitability with a 19.5% profit margin vs 0.0%. ADVB trades at a lower P/E of 2.1x. A earns a higher WallStSmart Score of 63/100 (C+).

A

Buy

63

out of 100

Grade: C+

Growth: 5.3Profit: 8.5Value: 4.7Quality: 6.0
Piotroski: 3/9Altman Z: 1.99

ADVB

Avoid

33

out of 100

Grade: F

Growth: 4.3Profit: 3.0Value: 6.7Quality: 7.8
Piotroski: 4/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ASignificantly Overvalued (-66.4%)

Margin of Safety

-66.4%

Fair Value

$77.48

Current Price

$146.80

$69.32 premium

UndervaluedFair: $77.48Overvalued

Intrinsic value data unavailable for ADVB.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

A1 strengths · Avg: 8.0/10
Operating MarginProfitability
25.6%8/10

Strong operational efficiency at 25.6%

ADVB3 strengths · Avg: 10.0/10
P/E RatioValuation
2.1x10/10

Attractively priced relative to earnings

Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0810/10

Conservative balance sheet, low leverage

Areas to Watch

A3 concerns · Avg: 3.7/10
P/E RatioValuation
29.0x4/10

Moderate valuation

Altman Z-ScoreHealth
1.994/10

Grey zone — moderate risk

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

ADVB4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$14.62M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : A

The strongest argument for A centers on Operating Margin. Profitability is solid with margins at 19.5% and operating margin at 25.6%. PEG of 1.25 suggests the stock is reasonably priced for its growth.

Bull Case : ADVB

The strongest argument for ADVB centers on P/E Ratio, Price/Book, Debt/Equity.

Bear Case : A

The primary concerns for A are P/E Ratio, Altman Z-Score, Piotroski F-Score.

Bear Case : ADVB

The primary concerns for ADVB are Revenue Growth, EPS Growth, Market Cap.

Key Dynamics to Monitor

A profiles as a mature stock while ADVB is a value play — different risk/reward profiles.

A is growing revenue faster at 8.1% — sustainability is the question.

A generates stronger free cash flow (439M), providing more financial flexibility.

Monitor DIAGNOSTICS & RESEARCH industry trends, competitive dynamics, and regulatory changes.

Bottom Line

A scores higher overall (63/100 vs 33/100), backed by strong 19.5% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Agilent Technologies Inc

HEALTHCARE · DIAGNOSTICS & RESEARCH · USA

Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global headquarters is located in Santa Clara, California.

Advanced Biomed Inc. Common Stock

HEALTHCARE · DIAGNOSTICS & RESEARCH · USA

Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies and provides them for precision oncology detection, diagnosis, and treatment in Taiwan. The company is headquartered in New York, New York.

Want to dig deeper into these stocks?